SOTAC PHARMACEUTICALS
Back to Cashflow Statement
|
SOTAC PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-1.85 Cr | ₹-6.26 Cr | ₹9.61 Cr | ₹0.00 Cr | ₹-0.16 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SOTAC PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-1.85 Cr |
| Mar2024 | ₹-6.26 Cr |
| Mar2023 | ₹9.61 Cr |
| Mar2022 | ₹0.00 Cr |
| Mar2021 | ₹-0.16 Cr |
How is Net Cash Inflow / Outflow of SOTAC PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.85 Cr | Negative | |
| Mar2024 | ₹-6.26 Cr | Negative | |
| Mar2023 | ₹9.61 Cr | 192,000.00 | |
| Mar2022 | ₹0.00 Cr | Positive | |
| Mar2021 | ₹-0.16 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹100.0 Cr | -5.3% | -15.1% | -25.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -5.3% |
-15.1% |
-25.9% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses